PMC2 HEALTH CONDITIONS IN POSTMENOPAUSAL WOMEN AND IMPLICATIONS FOR THE DESIGN OF CLINICAL TRIALS OF AROMATASE INHIBITORS
May 1, 2006, 00:00 AM
10.1016/S1098-3015(10)64478-6
https://www.valueinhealthjournal.com/article/S1098-3015(10)64478-6/fulltext
Section Title :
Section Order :
390
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)64478-6&doi=10.1016/S1098-3015(10)64478-6